Gross Profit - S2Medical AB (publ) (STO:S2M) - Alpha Spread
S

S2Medical AB (publ)
STO:S2M

Watchlist Manager
S2Medical AB (publ)
STO:S2M
Watchlist
Price: 0.024 SEK Market Closed
Market Cap: 6.4m SEK
Have any thoughts about
S2Medical AB (publ)?
Write Note

S2Medical AB (publ)
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

S2Medical AB (publ)
Gross Profit Peer Comparison

Comparables:
O
OSSD
XVIVO
D
DOXA
BACTI B
V
VIMIAN

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
S
S2Medical AB (publ)
STO:S2M
Gross Profit
kr9.5m
CAGR 3-Years
14%
CAGR 5-Years
12%
CAGR 10-Years
N/A
O
OssDsign AB
STO:OSSD
Gross Profit
kr83.6m
CAGR 3-Years
74%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Xvivo Perfusion AB
STO:XVIVO
Gross Profit
kr518.2m
CAGR 3-Years
48%
CAGR 5-Years
28%
CAGR 10-Years
25%
D
Doxa AB
STO:DOXA
Gross Profit
kr11.7m
CAGR 3-Years
125%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Bactiguard Holding AB
STO:BACTI B
Gross Profit
kr61.3m
CAGR 3-Years
-15%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
V
Vimian Group AB
STO:VIMIAN
Gross Profit
€162.6m
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is S2Medical AB (publ)'s Gross Profit?
Gross Profit
9.5m SEK

Based on the financial report for Jun 30, 2024, S2Medical AB (publ)'s Gross Profit amounts to 9.5m SEK.

What is S2Medical AB (publ)'s Gross Profit growth rate?
Gross Profit CAGR 5Y
12%

Over the last year, the Gross Profit growth was 127%. The average annual Gross Profit growth rates for S2Medical AB (publ) have been 14% over the past three years , 12% over the past five years .

Back to Top